Companies/MediPharm Labs Corp.

Company profile

MediPharm Labs Corp.

OTC: MEDIF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Barrie, ONReports USD

#488 of 1,394 Healthcare companies by revenue49th-percentile growth

EA Score

61C

FH 63DQ —GM 62SS 49

v0.1 · 45/100 weight · provisional

↑ balance-sheet leverage, 3-yr revenue growth · ↓ listing tenure, Piotroski F

Methodology →

Revenue TTM

$31.3M

Rev growth YoY (TTM)

+1.4%

Net income (FY)

-$5.9M

Employees

166

Market cap

$21.1M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$32.3M45.1M CAD2025

Net income-$5.9M-8.3M CAD2025

Operating income-$6.2M-8.6M CAD2025

Total assets$33.3M45.7M CAD2025

Liabilities$7.2M9.9M CAD2025

Equity$26.1M35.8M CAD2025

Revenue trend

FY2018 – FY2025 · USD

$7.9M

FY18

$97.4M

FY19

$26.8M

FY20

$17.3M

FY21

$17.0M

FY22

$24.5M

FY23

$30.6M

FY24

$32.3M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

MediPharm Labs Corp. booked $32.3M in FY2025 revenue, growing 5.3% year over year — about the middle of the pack among Healthcare companies we track, at a -18.3% net margin.

Peers · Healthcare

BetterLife Pharma Inc.——Allarity Therapeutics, Inc.24D Guided Therapeutics, Inc.42D Serina Therapeutics, Inc.41D

Key facts

CEODavid A. Pidduck

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersBarrie, ON

ExchangeOTC: MEDIF

Employees166

IPO date2021-01-08

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.